Great Tree Pharmacy Co., Ltd. (TPEX:6469)
99.60
-0.90 (-0.90%)
At close: Dec 5, 2025
Great Tree Pharmacy Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 18,559 | 17,274 | 16,144 | 14,565 | 11,281 | 8,641 | Upgrade
|
| Revenue Growth (YoY) | 9.34% | 7.00% | 10.84% | 29.11% | 30.55% | 30.90% | Upgrade
|
| Cost of Revenue | 13,261 | 12,432 | 11,658 | 10,554 | 8,338 | 6,457 | Upgrade
|
| Gross Profit | 5,299 | 4,843 | 4,486 | 4,011 | 2,943 | 2,185 | Upgrade
|
| Selling, General & Admin | 4,571 | 4,041 | 3,680 | 3,149 | 2,451 | 1,959 | Upgrade
|
| Operating Expenses | 4,571 | 4,041 | 3,680 | 3,149 | 2,451 | 1,959 | Upgrade
|
| Operating Income | 727.15 | 801.19 | 805.56 | 861.87 | 492.31 | 225.31 | Upgrade
|
| Interest Expense | -79.43 | -58.9 | -57.5 | -45.85 | -35.13 | -32.87 | Upgrade
|
| Interest & Investment Income | 32.07 | 13.27 | 15.88 | 4.32 | 0.74 | 0.58 | Upgrade
|
| Earnings From Equity Investments | -1.09 | -0.79 | -0.93 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.68 | 3.73 | 1.53 | 12.54 | -1.86 | -1.69 | Upgrade
|
| Other Non Operating Income (Expenses) | 91.89 | 83.46 | 76.01 | 48.25 | 50.91 | 49.71 | Upgrade
|
| EBT Excluding Unusual Items | 769.9 | 841.95 | 840.55 | 881.14 | 506.97 | 241.03 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.4 | 4.39 | -0.72 | -0.43 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 2.98 | 0.42 | 0.5 | 1.12 | 0.1 | 0.9 | Upgrade
|
| Other Unusual Items | 1.24 | - | 1.49 | 0.5 | 2.6 | 1.48 | Upgrade
|
| Pretax Income | 774.52 | 846.77 | 841.82 | 882.33 | 509.67 | 243.41 | Upgrade
|
| Income Tax Expense | 161.42 | 166.8 | 175.34 | 181.83 | 101.91 | 50.74 | Upgrade
|
| Earnings From Continuing Operations | 613.1 | 679.96 | 666.48 | 700.5 | 407.76 | 192.67 | Upgrade
|
| Minority Interest in Earnings | 12.68 | 0.8 | -0.44 | -0.43 | -0.34 | 1.64 | Upgrade
|
| Net Income | 625.78 | 680.77 | 666.05 | 700.07 | 407.42 | 194.31 | Upgrade
|
| Net Income to Common | 625.78 | 680.77 | 666.05 | 700.07 | 407.42 | 194.31 | Upgrade
|
| Net Income Growth | -8.67% | 2.21% | -4.86% | 71.83% | 109.67% | 42.89% | Upgrade
|
| Shares Outstanding (Basic) | 149 | 149 | 147 | 145 | 143 | 138 | Upgrade
|
| Shares Outstanding (Diluted) | 156 | 154 | 155 | 150 | 148 | 143 | Upgrade
|
| Shares Change (YoY) | 1.61% | -0.33% | 3.19% | 1.51% | 3.36% | -0.62% | Upgrade
|
| EPS (Basic) | 4.19 | 4.57 | 4.54 | 4.83 | 2.86 | 1.41 | Upgrade
|
| EPS (Diluted) | 4.08 | 4.49 | 4.40 | 4.70 | 2.76 | 1.37 | Upgrade
|
| EPS Growth | -9.96% | 1.96% | -6.35% | 70.41% | 100.79% | 44.48% | Upgrade
|
| Free Cash Flow | 797.39 | 779.64 | 594.08 | 924.01 | 829.21 | 481.48 | Upgrade
|
| Free Cash Flow Per Share | 5.10 | 5.05 | 3.84 | 6.16 | 5.61 | 3.37 | Upgrade
|
| Dividend Per Share | 2.918 | 2.918 | 2.724 | 2.895 | 1.260 | 0.378 | Upgrade
|
| Dividend Growth | 7.15% | 7.15% | -5.93% | 129.89% | 233.29% | 20.04% | Upgrade
|
| Gross Margin | 28.55% | 28.03% | 27.79% | 27.54% | 26.09% | 25.28% | Upgrade
|
| Operating Margin | 3.92% | 4.64% | 4.99% | 5.92% | 4.36% | 2.61% | Upgrade
|
| Profit Margin | 3.37% | 3.94% | 4.13% | 4.81% | 3.61% | 2.25% | Upgrade
|
| Free Cash Flow Margin | 4.30% | 4.51% | 3.68% | 6.34% | 7.35% | 5.57% | Upgrade
|
| EBITDA | 995.73 | 1,069 | 1,046 | 1,071 | 663.11 | 361.55 | Upgrade
|
| EBITDA Margin | 5.37% | 6.19% | 6.48% | 7.35% | 5.88% | 4.18% | Upgrade
|
| D&A For EBITDA | 268.59 | 268.1 | 240.04 | 208.92 | 170.8 | 136.24 | Upgrade
|
| EBIT | 727.15 | 801.19 | 805.56 | 861.87 | 492.31 | 225.31 | Upgrade
|
| EBIT Margin | 3.92% | 4.64% | 4.99% | 5.92% | 4.36% | 2.61% | Upgrade
|
| Effective Tax Rate | 20.84% | 19.70% | 20.83% | 20.61% | 19.99% | 20.85% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.